Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Operating Costs and Expenses:
General and administrative	$ 2,201	$ 1,655
Research and development	2,977	2,597
Total Operating Costs and Expenses	5,178	4,252
Loss from Operations	(5,178)	(4,252)
Other Income (Expense):
Exchange income (loss)	6	(23)
Interest income	364	2
Total Other Income (Expense)	370	(21)
Net Loss before income taxes	(4,808)	(4,273)
Income tax benefit	330	0
Net Loss Attributable to Common Stockholders	$ (4,478)	$ (4,273)
Net Loss Per Share - Basic	$ (0.30)	$ (0.31)
Net Loss Per Share - Dilutive	$ (0.30)	$ (0.31)
Weighted average number of shares outstanding during the period - Basic	15,124,061	13,820,144
Weighted average number of shares outstanding during the period - Dilutive	15,124,061	13,820,144
Net Loss	$ (4,478)	$ (4,273)
Gain on foreign currency translation	374	181
Total comprehensive loss	$ (4,104)	$ (4,092)